| Acne |
1 |
1 |
| Pregnancy |
0 |
0.9 |
| Isotretinoin |
0 |
0.68 |
| Abortion |
0 |
0.65 |
| Rosacea |
0 |
0.64 |
| Contraception |
0 |
0.95 |
| Dermatitis |
0 |
0.21 |
| Grant |
0 |
0.19 |
| Travel Medicine |
0 |
0.12 |
| Child |
0 |
0.09 |
| Connecticut |
0 |
0.09 |
| Georgia |
0 |
0.09 |
| Pediatric Dermatology |
0 |
0.09 |
| Sterilization, Birth Control |
0 |
0.09 |
| Arizona |
0 |
0.06 |
| Biologic Therapy |
0 |
0.06 |
| Birth |
0 |
0.06 |
| California |
0 |
0.06 |
| Emergency Contraception |
0 |
0.06 |
| Psoriasis |
0 |
0.06 |
| Revenue and Practice Management |
0 |
0.06 |
| Skin and Soft Tissue Infection |
0 |
0.06 |
| Social Determinants of Health |
0 |
0.05 |
| Arkansas |
0 |
0.03 |
| Atopic Dermatitis |
0 |
0.03 |
| Crime |
0 |
0.03 |
| Dermatoses |
0 |
0.03 |
| LGBT |
0 |
0.03 |
| Patient Safety |
0 |
0.03 |
| Reproductive Health |
0 |
0.03 |
| Risk Evaluation and Mitigation Strategies |
0 |
0.03 |
| Risk Management |
0 |
0.03 |
| Salary and Compensation |
0 |
0.03 |
| Targeted Cancer Therapy |
0 |
0.03 |